Phase 1 Trial
The first stage of testing a new treatment in humans, focused primarily on safety, dosing, and side effects in a small group of volunteers.
In Detail
A Phase 1 trial is the earliest stage of clinical testing in humans. Its primary goal is to evaluate the safety profile of a new drug or treatment, determine the appropriate dosage range, and identify side effects. Phase 1 trials typically enroll between 20 and 100 healthy volunteers or patients, though cancer Phase 1 trials often enroll patients with advanced disease who have exhausted standard treatments. Researchers start with a very low dose and gradually increase it — a process called dose escalation — while closely monitoring participants for adverse reactions. These studies usually last several months and are conducted at specialized research centers with intensive medical oversight. Phase 1 trials also collect pharmacokinetic data, which describes how the body absorbs, distributes, metabolizes, and excretes the drug. Approximately 70% of Phase 1 drugs move on to Phase 2 testing. While Phase 1 trials are not designed to test whether a treatment works, researchers may observe preliminary signs of efficacy. Participants in Phase 1 trials receive extensive informed consent about the experimental nature of the study and the potential for unknown risks. These trials are a critical safety gateway — no treatment can advance without first demonstrating acceptable tolerability in humans.
Frequently Asked Questions
What does "Phase 1 Trial" mean in clinical trials?
The first stage of testing a new treatment in humans, focused primarily on safety, dosing, and side effects in a small group of volunteers.
Why is "phase 1 trial" important for patients?
Understanding phase 1 trial helps patients and caregivers navigate clinical trial participation with confidence. It is part of the broader clinical research process that ensures treatments are safe and effective before reaching patients.
Related Terms
Clinical Trial
A research study that tests a medical treatment, drug, device, or intervention in human volunteers to determine whether it is safe and effective.
Phase 2 Trial
The second stage of testing, which evaluates whether the treatment works for its intended condition and continues to assess safety in a larger group.
Adverse Event (AE)
Any undesirable medical occurrence in a clinical trial participant, whether or not it is caused by the treatment being studied.
Informed Consent
The process by which a potential participant learns the key facts about a clinical trial — including risks, benefits, and alternatives — before deciding whether to enroll.